Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2021-07-09 00:00:00 ET · period of report 2021-07-08 · accession 0001209191-21-046174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-09 | 2021-07-08 | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $49.70 | -48.0K | 452.2K | -10% | -$2.39M |
| D | 2021-07-09 | 2021-07-08 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +48.0K | 500.2K | +11% | +$99.8K |
| D | 2021-07-09 | 2021-07-08 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $0.00 | -48.0K | 126.7K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-08 | S | D | 17,230 | $49.15 | 482,969 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.44 to $49.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2021-07-08 | S | D | 23,803 | $49.71 | 459,166 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.44 to $50.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2021-07-08 | S | D | 6,372 | $50.96 | 452,794 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.45 to $51.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2021-07-08 | S | D | 595 | $51.64 | 452,199 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.60 to $51.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2021-07-08 | M | A | 48,000 | $2.08 | 500,199 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-07-08 | M | D | 48,000 | $0.00 | 126,725 | D | $2.08 · — to 2029-11-13 | 48,000 Common Stock | (F6) The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones. |